| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Other income | 0.3 | 0.6 | 0.1 |
| Total income | 20.2 | 20.9 | 18.6 |
| Net profit | -1.7 | -4.5 | 1.2 |
| Operating margin | -6.9% | -20.6% | 8.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, NSE: INTERCONTINENTAL. Figures extracted from the filing.
Medico Intercontinental Ltd: key numbers
- Share price
- ₹24.91
- Market cap
- ₹24.91 Cr
- Revenue (annual)
- ₹84.08 Cr
- Net profit (annual)
- ₹-3.20 Cr
- P/E (TTM)
- -6.3×Sector 42.2×
- Promoter holding
- 58.51%+1.36% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medico Intercontinental Ltd
All →Medico Intercontinental Annual General Meeting
Medico Intercontinental Ltd will convene its Annual General Meeting on September 30, 2026. The company announced book closure from September 24 to September 30, 2026.
Medico Intercontinental Q1 FY27 Results: Net Loss of ₹4 Cr, Loss Widens
Medico Intercontinental Ltd reported revenue from operations of ₹20.7 Cr (-3.3% YoY) and a net loss of ₹4 Cr for Q1 FY27.
- Key figure
- Net loss ₹4 Cr
Medico Intercontinental Board Meeting Date
Medico Intercontinental Ltd scheduled a board meeting on August 14, 2026, to consider and approve the unaudited standalone and consolidated financial results for the June quarter.
Medico Intercontinental Promoter Buying
Promoter Samir Dilipkumar Shah acquired 1,36,886 shares (1.37%) of Medico Intercontinental via open market purchase. Total promoter group holding increased to 60.48%.
Medico Intercontinental Promoter Buying: ₹0.54 Cr
Promoter Samir Dilipkumar Shah acquired 1,36,886 shares of Medico Intercontinental via open market. The transaction, valued at Rs. 0.54 Crore, increased his stake to 47.77%.
- Value
- ₹0.54 Cr
Medico Intercontinental Management Change
Medico Intercontinental re-appointed M/s. MJV & Co as Internal Auditors for the 2026-27 financial year. The firm brings extensive audit experience to the company.
- Execution
- F.Y. 2026-27